Ovarian Cancer 2021
DOI: 10.1136/ijgc-2021-esgo.460
|View full text |Cite
|
Sign up to set email alerts
|

740 ESGO certification for advanced ovarian cancer surgery: the experience of an oncology center to aim accreditation

Abstract: Stratifying by stage the residual tumour (OR=2.4; p=0.0001) , age (OR=1.9 P=0.0001), and the performance status (OR=1.2; p=0.03) resulted as independent survival prognostic factors according to Cox multivariate analysis. Conclusion* Our data suggest that patients aged !70 can tolerate radical surgical treatments in the same way as younger patients without a significant increase in morbidity and, obviously, without ignoring the appropriate geriatric precautions. Furthermore, maximal surgical effort with optimal… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles